Sign In
Buy RPRX
$53.57
+0.610 (+1.15%)
At Close: Jun 22, 2026
Royalty Pharma: Uncorrelated Yield From Pharmaceutical Product In Uncertain Times
03:19pm, Monday, 30'th Jan 2023
Royalty Pharma plc is an interesting investment fund that buys pharmaceutical royalties and generates a non-correlated yield. With the depressed biotech sector valuation and increasing cost of capital
5 Best and Worst Performing Health Care Stocks in December 2022
10:51pm, Monday, 23'rd Jan 2023
Despite inflation making it hard for the healthcare industry to manage its operating costs, there are a few positives that make this sector attractive to investors.
Royalty Pharma To Announce Fourth Quarter And Full Year 2022 Financial Results On February 15, 2023
08:25am, Wednesday, 18'th Jan 2023
NEW YORK, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its fourth quarter and full year 2022 financial results on Wednesday, February 15, 202
Royalty Pharma: An Attractive Business Model But An Uncertain Outcome For Vertex's CF Royalties
11:13pm, Monday, 09'th Jan 2023
Royalty Pharma purchases royalties on pharmaceutical products. Diversification provides some protection for investors and the company has invested in high quality assets.
Royalty Pharma agrees to buy Ionis Pharma royalties for $1.125 bln
09:24am, Monday, 09'th Jan 2023
Royalty Pharma Plc RPRX, -1.42% said Monday it agreed to pay up to $1.125 billion for drug royalties owned by Ionis Pharmaceuticals Inc. IONS, +1.00% . The royalties include Ionis' interests in Biogen
Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 9
04:15pm, Wednesday, 04'th Jan 2023
NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 11
100 Best Stocks Of 2022: Oil Stocks And Medicals Shine
06:00pm, Friday, 30'th Dec 2022
Medical and energy companies, including oil stocks, lead the list of the 100 best stocks in 2022. The post 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine appeared first on Investor's Business
Royalty Pharma to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference
04:26pm, Monday, 28'th Nov 2022
NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at the Evercore ISI 5th Annual HealthCONx Virtual C
Royalty Pharma plc (RPRX) Q3 2022 Results - Earnings Call Transcript
10:40am, Tuesday, 08'th Nov 2022
Royalty Pharma plc (NASDAQ:RPRX ) Q3 2022 Results Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants George Grofik - SVP, Head, IR & Communications Pablo Legorreta - Founder and
Royalty Pharma (RPRX) Surpasses Q3 Earnings and Revenue Estimates
09:48am, Tuesday, 08'th Nov 2022
Royalty Pharma (RPRX) delivered earnings and revenue surprises of 2.82% and 3.28%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Royalty Pharma (RPRX)
09:47am, Monday, 07'th Nov 2022
Royalty Pharma (RPRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Royalty Pharma (RPRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:19am, Tuesday, 01'st Nov 2022
Royalty Pharma (RPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Royalty Pharma to Announce Third Quarter 2022 Financial Results on November 8, 2022
08:30am, Tuesday, 18'th Oct 2022
NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2022 financial results on Tuesday, November 8, 2022 before the U.S.
Royalty Pharma to Present at Upcoming Investor Conferences
04:15pm, Tuesday, 06'th Sep 2022
NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of September:
These Are the 6 Stocks Warren Buffett Sold in the Second Quarter
05:30am, Saturday, 20'th Aug 2022
Buffett and his company Berkshire Hathaway sold $2.3 billion of its equity holdings in the second quarter of the year.
